<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01447004</url>
  </required_header>
  <id_info>
    <org_study_id>hushhirb</org_study_id>
    <nct_id>NCT01447004</nct_id>
  </id_info>
  <brief_title>a Case-control Study of the Association Between Heavy Mental and Children With Attention Deficit Hyperactivity Disorder in Korea</brief_title>
  <official_title>a Case-control Study of the Association Between Heavy Mental and Children With Attention Deficit Hyperactivity Disorder in Korea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hallym University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heavy metal has been reported that it can cause attention deficit and behavioral disturbance.&#xD;
      The investigators hypothesis is that heavy metal is associated with children with attention&#xD;
      deficit/hyperactivity disorder(ADHD).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects must meet DSM-IV criteria for ADHD based-on the K-Schedule for affective disorder&#xD;
        and schizophrenia(K-SADS-PL-K) interview&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects must meet DSM-IV criteria for ADHD based-on the K-Schedule for affective&#xD;
             disorder and schizophrenia(K-SADS-PL-K) interview&#xD;
&#xD;
               -  Subjects signed a written consent form voluntarily.&#xD;
&#xD;
               -  Patient 's assent to participate in the study and written informed consent form&#xD;
                  signed by one of the parents, parent surrogates, or legal guardian.&#xD;
&#xD;
               -  Subjects/parents, parent surrogates or legal guardian who can understand the&#xD;
                  participation of the study and voluntarily withdraw from the study at any time&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who have any history of bipolar disorder, psychotic disorder, and substance&#xD;
             use disorder, have been diagnosed with a pervasive developmental disorder, organic&#xD;
             brain disease and seizure disorder.&#xD;
&#xD;
          -  Subjects who have significant suicidal ideation or homicidal ideation&#xD;
&#xD;
          -  Subjects with mental retardation&#xD;
&#xD;
          -  Subjects with Tourette's syndrome requiring drug therapy.&#xD;
&#xD;
          -  Subjects who currently have a significant medical conditions (e.g. diseases of&#xD;
             cardiovascular, hepatic, renal, respiratory, glaucoma).&#xD;
&#xD;
          -  Subjects who have abnormalities in the ECG or show clinically significant&#xD;
             abnormalities of laboratory results, including serum chemistries and hematology.&#xD;
&#xD;
          -  Subjects who have been administrated alpha-2 adrenergic receptor&#xD;
             agonist,antidepressant, antipsychotic, benzodiazepines, modafinil, anticonvulsant&#xD;
             within recent 2 months.&#xD;
&#xD;
          -  Subjects who dyed their hair within 8 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hyun Ju Hong</last_name>
    <phone>+82-31-380-3750</phone>
    <email>hongdr@chol.com, hjhong@hallym.or.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hallym university sacred heart hospital</name>
      <address>
        <city>Anyang, Gyeonggi-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyun Ju Hong</last_name>
      <phone>+82-31-380-3750</phone>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <study_first_submitted>October 4, 2011</study_first_submitted>
  <study_first_submitted_qc>October 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2011</study_first_posted>
  <last_update_submitted>October 4, 2011</last_update_submitted>
  <last_update_submitted_qc>October 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

